(Q38191830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

review article

1 reference

title

Pluripotent stem cells as a potential tool for disease modelling and cell therapy in diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Amélie Bonnefond

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

Annelise Bennaceur Griscelli

9 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Philippe Froguel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Annelise Bennaceur-Griscelli

3

1 reference

30 August 2017

language of work or name

1 reference

1 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

Stem Cell Reviews and Reports

9 March 2020

published in

1 reference

30 August 2017

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

327-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

Embryonic stem cell lines derived from human blastocysts

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Generation of pluripotent stem cells from adult mouse liver and stomach cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Molecular mechanisms controlling the cell cycle in embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Oct4 maintains the pluripotency of human embryonic stem cells by inactivating p53 through Sirt1-mediated deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Induced pluripotent stem cells generated without viral integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Mortality trends in men and women with diabetes, 1971 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Type 1 diabetes: etiology, immunology, and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

The emerging genetic architecture of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

The emerging genetics of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Beta-cell replacement for insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Generation of pluripotent stem cells from patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Generation of insulin-secreting islet-like clusters from human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Generation of insulin-producing islet-like clusters from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

A small molecule that directs differentiation of human ESCs into the pancreatic lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Directed differentiation of human embryonic stem cells towards a pancreatic cell fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Initial cell seeding density influences pancreatic endocrine development during in vitro differentiation of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

In vitro derivation of functional insulin-producing cells from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Efficient differentiation of human embryonic stem cells to definitive endoderm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Noggin, retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

FGF4 and retinoic acid direct differentiation of hESCs into PDX1-expressing foregut endoderm in a time- and concentration-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Nodal signals pattern vertebrate embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Development of definitive endoderm from embryonic stem cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Preparation of pancreatic β-cells from human iPS cells with small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

A novel chemically directed route for the generation of definitive endoderm from human embryonic stem cells based on inhibition of GSK-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Dynamic signaling network for the specification of embryonic pancreas and liver progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Biphasic induction of Pdx1 in mouse and human embryonic stem cells can mimic development of pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

VMAT2 identified as a regulator of late-stage β-cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

PAX4 enhances beta-cell differentiation of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

iPSC-derived β cells model diabetes due to glucokinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Generation of homogeneous PDX1(+) pancreatic progenitors from human ES cell-derived endoderm cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Prospects for the use of nuclear transfer in human transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Viable offspring derived from fetal and adult mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Human embryonic stem cells derived by somatic cell nuclear transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Creation of a registry for human embryonic stem cells carrying an inherited defect: joint collaboration between ESHRE and hESCreg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Human embryonic stem cell lines with genetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Induced pluripotent stem cell technology for the study of human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

iPS cells in type 1 diabetes research and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

The Ink4/Arf locus is a barrier for iPS cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Senescence impairs successful reprogramming to pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Metastable pluripotent states in NOD-mouse-derived ESCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Generation of mouse induced pluripotent stem cells without viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Generation of induced pluripotent stem cells using recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Strategies and new developments in the generation of patient-specific pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Why myc? An unexpected ingredient in the stem cell cocktail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

c-Myc is dispensable for direct reprogramming of mouse fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Stimulus-triggered fate conversion of somatic cells into pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Bidirectional developmental potential in reprogrammed cells with acquired pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Insulin-producing cells derived from stem cells: recent progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Immunological applications of stem cells in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

Defining the nature of human pluripotent stem cell progeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9503-6

10.1007/S12015-014-9503-6

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 March 2020

1048164525

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24577791%20AND%20SRC:MED&resulttype=core&format=json